08048035968

1. General Information

MYFORTIC-S 360 mg is an immunosuppressant containing mycophenolate sodium, which delivers the active substance mycophenolic acid. It reduces certain immune-system responses that can attack a transplanted organ. It is a prescription medicine and should be used under the supervision of a transplant specialist or other qualified healthcare professional.

Phoenix Exim is presented as a medicine exporter from Nagpur, India, supplying pharmaceutical products to international markets including the USA, UK, Australia, Singapore, Canada, South Korea and UAE, subject to applicable import and prescription regulations.

2. Product Information

  • Product: MYFORTIC-S 360 mg Tablets
  • Active ingredient: Mycophenolic acid, as mycophenolate sodium
  • Strength: 360 mg
  • Dosage form: Delayed-release/gastro-resistant tablet
  • Medicine class: Immunosuppressant
  • Route: Oral
  • Typical therapeutic area: Organ transplantation
  • Prescription status: Prescription medicine

Myfortic is available in 180 mg and 360 mg strengths.

3. Uses of MYFORTIC-S 360 mg

MYFORTIC is used as part of an immunosuppressive treatment regimen to help prevent rejection of a transplanted kidney. It is generally used together with other anti-rejection medicines, such as ciclosporin and corticosteroids, according to the prescribing regimen.

4. Benefits of This Medicine

Potential therapeutic benefits include:

  • Helps suppress excessive immune-system activity.
  • Helps reduce the risk of immune-mediated rejection of a transplanted kidney.
  • Provides mycophenolic acid through a delayed-release formulation.
  • Can be incorporated into a combination immunosuppressive regimen prescribed after transplantation.

Important: The medicine does not independently guarantee prevention of rejection; its effectiveness depends on the complete treatment regimen and adherence to the transplant team's instructions.

5. Side Effects of MYFORTIC-S 360 mg

Because mycophenolate suppresses the immune system, it can increase susceptibility to infections and may affect blood-cell counts. Gastrointestinal effects can also occur. Serious risks include certain malignancies, severe infections and blood abnormalities.

Patients should contact their healthcare professional promptly if they develop symptoms suggesting a serious infection, unusual bleeding or bruising, persistent fever, or other concerning symptoms.

6. Common Side Effects

Possible side effects include:

  • Diarrhea
  • Nausea
  • Abdominal discomfort or pain
  • Vomiting
  • Headache
  • Fatigue
  • Indigestion
  • Changes in blood-cell counts

The exact frequency can vary according to the treatment regimen and patient population. Gastrointestinal symptoms and hematological abnormalities are also recognized in cases of excessive exposure/overdose.

7. How to Use

Take MYFORTIC-S exactly as prescribed by your transplant specialist.

  • Swallow the tablet whole with water.
  • Do not crush, chew or break the delayed-release tablet.
  • Take it consistently according to the prescribed schedule.
  • Do not change the dose or stop treatment without consulting your doctor.
  • If you miss a dose, follow the instructions provided by your healthcare professional rather than taking an extra dose.

The correct dose and treatment duration are individualized according to the transplant regimen and other medicines being used.

8. How MYFORTIC-S Works

Mycophenolic acid inhibits inosine monophosphate dehydrogenase (IMPDH), an enzyme involved in the production of guanosine nucleotides. T and B lymphocytes rely heavily on this pathway for proliferation, so inhibiting it reduces the ability of these immune cells to multiply and mount an immune response against the transplanted organ.

9. Safety Advice

  • Pregnancy: Mycophenolate is associated with an increased risk of pregnancy loss and congenital malformations. Women who could become pregnant require appropriate pregnancy-prevention measures and medical guidance.
  • Infections: Immunosuppression can increase susceptibility to infections. Report persistent fever or other signs of infection promptly.
  • Blood monitoring: Your doctor may order regular blood tests to monitor blood-cell counts and other parameters.
  • Cancer risk: Long-term immunosuppression can increase the risk of certain malignancies, including lymphoma and skin cancers.
  • Allergy: Do not use it if you have a known hypersensitivity to mycophenolate sodium, mycophenolic acid, mycophenolate mofetil or relevant ingredients.
  • Drug interactions: Tell your doctor about all prescription medicines, OTC medicines, vitamins and supplements you use.
  • Keep the tablets out of reach of children and store them according to the product label.

10. Frequently Asked Questions (FAQs)

Q1. What is MYFORTIC-S 360 mg?
MYFORTIC-S 360 mg contains mycophenolic acid as mycophenolate sodium and is an immunosuppressive medicine used in transplant medicine.

Q2. What is MYFORTIC-S 360 mg mainly used for?
It is primarily used as part of therapy to help prevent rejection following kidney transplantation.

Q3. Can MYFORTIC-S be stopped suddenly?
No. Stopping immunosuppressive treatment without medical advice can increase the risk of transplant rejection.

Q4. Can the 360 mg tablet be crushed?
No. Because it is a delayed-release/gastro-resistant formulation, it should generally be swallowed whole. Follow the product-specific prescribing information.

Q5. Does MYFORTIC-S weaken the immune system?
Yes. Its therapeutic action involves suppressing specific immune responses, which can also increase susceptibility to infections.

Q6. Is MYFORTIC-S available in other strengths?
Myfortic is available in 180 mg and 360 mg tablet strengths in referenced product information.

Q7. Is MYFORTIC-S a prescription medicine?
Yes. It should be used under appropriate medical supervision.

Q8. Is MYFORTIC-S suitable during pregnancy?
Mycophenolate carries significant pregnancy-related risks and requires strict medical supervision and appropriate pregnancy-prevention measures.

11. Substitutes for MYFORTIC-S 360 mg

Potential alternatives or substitutes may contain the same active ingredient, mycophenolate sodium, or a related medicine such as mycophenolate mofetil. However, these products are not automatically interchangeable because their formulations, dosing and pharmacokinetic characteristics can differ.

Examples of products containing mycophenolate sodium include other brands/generics of mycophenolate sodium 360 mg. The appropriate substitute should be selected by the prescribing transplant physician or pharmacist.

12. SEO Keywords

  • MYFORTIC-S 360 mg Tablets
  • Myfortic 360 mg tablets
  • Myfortic 360 mg exporter from India
  • Myfortic 360 mg supplier India
  • Mycophenolate sodium 360 mg tablets
  • Mycophenolic acid 360 mg tablets
  • Myfortic 360 mg pharmaceutical exporter
  • Myfortic 360 mg medicine supplier
  • Myfortic 360 mg tablets exporter Nagpur
  • Mycophenolate sodium tablets exporter India
  • Myfortic 360 mg for kidney transplant
  • Myfortic 360 mg immunosuppressant
  • Myfortic 360 mg transplant medicine
  • Myfortic 360 mg tablets USA supplier
  • Myfortic 360 mg tablets UK supplier
  • Myfortic 360 mg tablets Australia supplier
  • Myfortic 360 mg tablets Singapore supplier
  • Myfortic 360 mg tablets Canada supplier
  • Myfortic 360 mg tablets South Korea supplier
  • Myfortic 360 mg tablets UAE supplier
  • Mycophenolate sodium medicine exporter India
  • kidney transplant immunosuppressant supplier
  • prescription transplant medicines exporter
  • pharmaceutical medicine exporter from Nagpur India
  • Phoenix Exim Myfortic 360 mg supplier
Aug 19th, 2026 3:36 PM

Keywords